secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001493152-24-034182
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics' shareholders approve capital stock decrease, elect directors
----------------------------------------------------------------------------

- Shareholders elected Richard Cilento and Robert Hoffman as Class I directors for terms expiring 2027; both received over 47M votes for.
- Capital Decrease Amendment to reduce authorized capital stock approved with ~48.2M for, 11K against; filed Aug 27.
- Clarifying Amendment to eliminate obsolete provisions approved; Amended and Restated Certificate of Incorporation effective Aug 27.
- WithumSmith+Brown ratified as independent auditor for FY2024 with 54.95M for votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224034182/0001493152-24-034182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224034182/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer